Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir–Rilpivirine in People With HIV Who Are Virally Unsuppressed

Abstract

Multilevel strategies to support LA-CAB/RPV implementation for PWH without VS are required, which may necessitate additional resources in some settings to implement safely and effectively. Advocacy to eliminate outer-context barriers, including prior authorizations and specialty pharmacy restrictions, is needed.